These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9777316)

  • 1. Domperidone. A review of its use in diabetic gastropathy.
    Prakash A; Wagstaff AJ
    Drugs; 1998 Sep; 56(3):429-45. PubMed ID: 9777316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domperidone: a peripherally acting dopamine2-receptor antagonist.
    Barone JA
    Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
    Brown CK; Khanderia U
    Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domperidone is more effective than cisapride in children with diabetic gastroparesis.
    Franzese A; Borrelli O; Corrado G; Rea P; Di Nardo G; Grandinetti AL; Dito L; Cucchiara S
    Aliment Pharmacol Ther; 2002 May; 16(5):951-7. PubMed ID: 11966504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic gastroparesis. A critical reappraisal of new treatment strategies.
    Drenth JP; Engels LG
    Drugs; 1992 Oct; 44(4):537-53. PubMed ID: 1281070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and treatment.
    Koch KL
    Dig Dis Sci; 1999 Jun; 44(6):1061-75. PubMed ID: 10389675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetic gastropathy].
    Hongo M; Toyota T
    Nihon Rinsho; 1991 Feb; 49 Suppl():227-31. PubMed ID: 2033810
    [No Abstract]   [Full Text] [Related]  

  • 8. Contractile mechanisms of action of gastroprokinetic agents: cisapride, metoclopramide, and domperidone.
    Orihata M; Sarna SK
    Am J Physiol; 1994 Apr; 266(4 Pt 1):G665-76. PubMed ID: 8179003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
    Patterson D; Abell T; Rothstein R; Koch K; Barnett J
    Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disorders of gastric emptying in diabetes. II. Treatment].
    Czambor-Ksiazek E; Pokrzywnicki W; Grzeszczak W; Duda G
    Wiad Lek; 1997; 50(1-3):39-41. PubMed ID: 9297356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domperidone, a new dopamine antagonist.
    Champion MC; Hartnett M; Yen M
    CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.
    Van Outryve M; De Nutte N; Van Eeghem P; Gooris JP
    Scand J Gastroenterol Suppl; 1993; 195():47-52; discussion 52-3. PubMed ID: 8516658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment.
    Koch KL; Stern RM; Stewart WR; Vasey MW
    Am J Gastroenterol; 1989 Sep; 84(9):1069-75. PubMed ID: 2773901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis.
    Soykan I; Sarosiek I; McCallum RW
    Am J Gastroenterol; 1997 Jun; 92(6):976-80. PubMed ID: 9177513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group.
    Silvers D; Kipnes M; Broadstone V; Patterson D; Quigley EM; McCallum R; Leidy NK; Farup C; Liu Y; Joslyn A
    Clin Ther; 1998; 20(3):438-53. PubMed ID: 9663360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current role of antidopaminergic drugs in pediatrics].
    Cinquetti M; Bonetti P; Bertamini P
    Pediatr Med Chir; 2000; 22(1):1-7. PubMed ID: 11387760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of gastric emptying].
    Jian R
    Presse Med; 1992 Jun; 21(23):1072-8. PubMed ID: 1387939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
    Soykan I; Sarosiek I; Shifflett J; Wooten GF; McCallum RW
    Mov Disord; 1997 Nov; 12(6):952-7. PubMed ID: 9399220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prokinetics in patients with gastroparesis: a systematic analysis.
    Sturm A; Holtmann G; Goebell H; Gerken G
    Digestion; 1999; 60(5):422-7. PubMed ID: 10473966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.